Home › Funds › Jupiter Topco LLC › PCVX
Jupiter Topco LLC position in PCVX
VAXCYTE INC · Health Care
Jupiter Topco LLC reported holding 17,965,847 shares of PCVX (VAXCYTE INC) in its Q2 2026 13F filing — a position valued at US$1.04B, representing 0.43% of its reported portfolio and ranking #42 among its reported holdings. Jupiter Topco LLC first reported this position in Q2 2026.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How Jupiter Topco LLC's PCVX position evolved
Jupiter Topco LLC first disclosed a stake in PCVX in Q2 2026 at 17,965,847 shares (US$1.04B).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 17.97M | $1.04B | New |
About PCVX and 13F data
PCVX (VAXCYTE INC) is a Health Care company. 35 other funds we track also report a position in PCVX — the largest reported positions include Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M), RA CAPITAL MANAGEMENT, L.P. (US$667.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PCVX
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- T. Rowe Price Investment Management, Inc. 12.21M sh · $709.62M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 11.47M sh · $667.02M · Q2 2026
- Deep Track Capital, LP 4.30M sh · $249.96M · Q2 2026
- Kynam Capital Management, LP 2.92M sh · $169.88M · Q2 2026
- Caligan Partners LP 2.19M sh · $127.23M · Q2 2026
- Paradigm Biocapital Advisors LP 2.13M sh · $123.69M · Q2 2026
- Bellevue Group AG 1.97M sh · $114.63M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- MAVERICK CAPITAL LTD 1.61M sh · $93.78M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.43M sh · $82.86M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.38M sh · $80.23M · Q2 2026
More on Jupiter Topco LLC
FAQ
How long has Jupiter Topco LLC held PCVX?
Jupiter Topco LLC has disclosed PCVX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Jupiter Topco LLC's current position in PCVX?
As of Q2 2026, Jupiter Topco LLC holds 17.97M shares of PCVX (VAXCYTE INC), valued at $1.04B, representing 0.43% of its reported portfolio and ranking #42.
Has Jupiter Topco LLC been buying or selling PCVX?
In the latest 13F filing (Q2 2026), Jupiter Topco LLC newly opened its position in PCVX.
Which other funds hold PCVX?
Other major institutional holders of PCVX include Janus Henderson Group, T. Rowe Price Investment Management, Inc., RA CAPITAL MANAGEMENT, L.P., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.